홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Cesium carbonate → ethyl 3-[4-({(tert-butoxycarbonyl)[(1R)-1-(1-naphthyl)ethyl]amino}methyl)-3-phenylpiperidin-1-yl]benzoate

HRID 1691730
노트
인쇄 미리보기

반응식

HRID 1691730 반응식
O1CCOCC1.[C:7]([O:11][C:12](=[O:39])[N:13]([C@@H:27]([C:29]1[C:38]2[C:33](=[CH:34][CH:35]=[CH:36][CH:37]=2)[CH:32]=[CH:31][CH:30]=1)[CH3:28])[CH2:14][CH:15]1[CH2:20][CH2:19][NH:18][CH2:17][CH:16]1[C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1)([CH3:10])([CH3:9])[CH3:8].I[C:41]1[CH:42]=[C:43]([CH:49]=[CH:50][CH:51]=1)[C:44]([O:46][CH2:47][CH3:48])=[O:45].C(=O)([O-])[O-].[Cs+].[Cs+]>C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd].C1(P(C2CCCCC2)C2C=CC=CC=2C2C=CC=CC=2N(C)C)CCCCC1.C(OCC)(=O)C.C(O)(C)(C)C>[C:7]([O:11][C:12]([N:13]([CH2:14][CH:15]1[CH2:20][CH2:19][N:18]([C:41]2[CH:42]=[C:43]([CH:49]=[CH:50][CH:51]=2)[C:44]([O:46][CH2:47][CH3:48])=[O:45])[CH2:17][CH:16]1[C:21]1[CH:22]=[CH:23][CH:24]=[CH:25][CH:26]=1)[C@@H:27]([C:29]1[C:38]2[C:33](=[CH:34][CH:35]=[CH:36][CH:37]=2)[CH:32]=[CH:31][CH:30]=1)[CH3:28])=[O:39])([CH3:8])([CH3:9])[CH3:10]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 4

HCID 10796Cesium carbonateHCID 312751,4-Dioxane2회HCID 143542Ethyl 3-iodobenzoateHCID 59178521HCID 59178521, 화합물

생성물 1

HCID 66906240ethyl 3-[4-({(tert-butoxycarbonyl)[(1R)-1-(1-naphthyl)ethyl]amino}methyl)-3-phenylpiperidin-1-yl]benzoate수율 81%

시약·촉매·용매 4

HCID 2734217
2-(Dicyclohexylphosphino)-2'-(dimethylamino)biphenyl
촉매
HCID 9811564Bis(dibenzylideneacetone)palladium촉매
HCID 6386tert-Butanol용매
HCID 8857Ethyl Acetate용매

반응 조건

온도
100 °C

실험 절차

To a mixture of 2.3 mg of tris(dibenzylideneacetone)dipalladium(0), 1.9 mg of 2-(dicyclohexylphosphino)-2′-(dimethylamino)biphenyl, and 0.5 mL of 1,4-dioxane were added 100 mg of tert-butyl[(1R)-1-(1-naphthyl)ethyl][(3-phenylpiperidin-4-yl)methyl]carbamate, 83.8 mg of ethyl 3-iodobenzoate, 105 mg of cesium carbonate, 1.0 mL of 1,4-dioxane, and 1.5 mL of t-butanol, followed by stirring at 100° C. overnight. After cooling to room temperature, to the reaction mixture was added ethyl acetate, the insolubles were removed, and the solvent was removed by distillation under reduced pressure. The residue was purified by silica gel column chromatography (hexane-ethyl acetate) to obtain 108 mg of ethyl 3-[4-({(tert-butoxycarbonyl)[(1R)-1-(1-naphthyl)ethyl]amino}methyl)-3-phenylpiperidin-1-yl]benzoate as a pale yellow foamy substance. ESI+: 593

후처리

  1. temperatureAfter cooling to room temperature, to the reaction mixture
  2. customthe insolubles were removed
  3. customthe solvent was removed by distillation under reduced pressure
  4. customThe residue was purified by silica gel column chromatography (hexane-ethyl acetate)

출처 및 근거

ORD 기록
ord-73d9afbf22ea4b9b8363dc939f337a8d
출처 데이터셋
uspto-grants-2012_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08153658B2

반응 노트

불러오는 중…

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트